Eikonizo Therapeutics

Healthcare & Life Sciences

Recent Finacing

Equity

Recent Raise

Undisclosed

Eikonizo Therapeutics is a biotechnology company developing disease-modifying therapies for neurodegenerative and cardiorenal diseases, focusing on a novel HDAC6 inhibitor.